Peginterferon alfa-2b, Ribavirin

Pegasys Copegus Combination Pack

180MCG/0.5ML & 1200MGUnited StatesWithdrawnAuthorised 4 Jun 2004

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Pegasys RBVCanada · 180 MCG / 0.5 ML + 200 MG / TAB · Solution, Tablet · Hoffmann-LA Roche LimitedSame brand
Pegasys RBVCanada · 180 MCG / ML + 200 MG / TAB · Solution, Tablet · Hoffmann-LA Roche LimitedSame brand
PegetronCanada · 80 MCG / 0.5 ML + 200 MG / CAP · Capsule, Powder For Solution · Merck Canada INCSame substance

Documents

The official texts, at the regulator.

Register entryFDA

Sources and licences

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Peginterferon alfa-2b, Ribavirin

Pegasys Copegus Combination Pack

180MCG/0.5ML & 1200MGUnited StatesWithdrawnAuthorised 4 Jun 2004

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Register entryFDA

Sources and licences

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Compiled by Prognia from the public register below; the register’s text is the official one.

U.S. Food and Drug Administration

FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.

Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions · Added 11 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Peginterferon alfa-2b, Ribavirin
Strength: 180MCG/0.5ML & 1200MG
Register: United States (FDA)
Status: Withdrawn
Status in the register: Voluntarily Revoked / Disc
Authorised: 4 Jun 2004
Registration: BLA 125083
Marketing authorisation holder: Hoffmann-La Roche Inc.
Procedure: 351(a)
Supply: Disc

Withdrawn

PegIntron/ Rebetol Combo PackPeginterferon alfa-2b + Ribavirin · 80MCG/0.5ML & 200MGUnited StatesWithdrawn

PegIntron/ Rebetol Combo PackPeginterferon alfa-2b + Ribavirin · 120MCG/0.5ML & 200MGUnited StatesWithdrawn

PegIntron/ Rebetol Combo PackPeginterferon alfa-2b + Ribavirin · 150MCG/0.5ML & 200MGUnited StatesWithdrawn

PegIntron/ Rebetol Combo PackPeginterferon alfa-2b + Ribavirin · 50MCG/0.5ML & 200MGUnited StatesWithdrawn